Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Beth Israel Medical Center, New York

Weill Medical College, New York

New York Hospital Queens, Flushing

Albany Medical College, Albany

University of Rochester, Rochester

University Of Pennsylvania, Philadelphia

Philadelphia FIGHT, Philadelphia

Thomas Jefferson University, Philadelphia

Dupont Circle Physician's Group, Washington D.C.

Johns Hopkins University, Lutherville

Wake Forest University Health Sciences, Winston-Salem

Duke University Health System, Durham

East Carolina University The Brody School of Medicine, Infectious Diseases, Greenville

Carolinas Medical Center--Myer's Park, Charlotte

Atlanta ID Group, Atlanta

AIDS Research Consortium of Atlanta, Atlanta

Mercer University, Mercer Medicine, Macon

Infectious Diseases Associates of NW FL, Pensacola

Midland Florida Clinical Research Center, LLC, DeLand

Orlando Immunology Center, Orlando

Valuhealthmd/Idocf, Orlando

AIDS Research and Treatment Center of the Treasure Coast, Vero Beach

Therafirst Medical Center, Fort Lauderdale

Gary J.Richmond, MD, P.A., Fort Lauderdale

Triple O Research Institute PA, West Palm Beach

Hillsborough County Health Department, Tampa

St. Joseph's Comprehensive Research Institute, Tampa

Midway Immunology and Research Center, Ft. Pierce

The Ohio State University Medical Center, Columbus

Summa Health System CARE Center, Akron

Henry Ford Health System, Detroit

Abbott Northwestern Hospital, Minneapolis

The Ruth M. Rothstein CORE Center, Chicago

Howard Brown Health Center, Chicago

Central West Clinical Research, St Louis

The Kansas City Free Health Clinic/ KC Care Clinic, Kansas City

North Texas infectious Diseases Consultants, PA, Dallas

DCOL Center for Clinical Research, Longview

Therapeutic Concepts, PA, Houston

Gordon E. Crofoot MD PA, Houston

University of Utah, Salt Lake City

Pueblo Family Physicians, Ltd., Phoenix

Southwest CARE Center, Santa Fe

Peter J Ruane, MD, Inc., Los Angeles

Pacific Oaks Medical Group, Beverly Hills

Long Beach Education and Research Consultants, Long Beach

Kaiser San Francisco Division of Research, San Francisco

Kaiser Permanente, Hayward

Kaiser Permanente Medical Group, Sacramento

Peter Shalit, MD, Seattle

Clinical Alliance for Research & Education - Infectious Diseases (CARE-ID), Annandale

Brigham and Women's Hospital, Boston

Harvard Medical School, Boston

Baystate Infectious Diseases Clinical Research, Springfield

South Jersey Infectious Disease, Somers Point

The Miriam Hospital, Providence

Southern Alberta Clinic, Calgary

Vancouver ID Research & Care Centre Society, Vancouver

Wrha - Health Sciences Centre Winnipeg, Winnipeg

Ottawa Hospital - General Campus, Ottawa

Maple Leaf Research, Toronto

Clinique médicale L'actuel, Montreal